Language
English
Chinese
COMPANY
About
History
Management
Benefits
Employee-Employer Relationships
Join Us
|
Technology & Service
Product List
CMO & CDMO
Analytical Development
Co-development on Early-stage Products
|
PLANT
Location
Chunan
Tainan
Tainan Injection Plant
Inspection History
|
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
|
SLC BioPharm
Carbapenem
PRODUCT
Paliperidone Palmitate
Cetrorelix Acetate
Ganirelix Acetate
Plecanatide
Prucalopride Succinate
Brinzolamide
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
Press
2020.06.24
/
In order to progress our business extension and bloom from a brand new image, we hereby announce to change our company name in Chinese from now on
2019.03.26
/
U.S. Food and Drug Administration (FDA) approved Savior’s ANDA of Ertapenem 1g in Mar, 2019.
2017.08.17
/
Savior Lifetec Co., Ltd. - Investor Conference 2017
2016.12.08
/
Savior Lifetec Co., Ltd. - Active Pharmaceutical Ingredient (API) site in Nanke, Tainan passes MHRA UK Audit
2016.11.02
/
Savior Lifetec Co., Ltd. -Active Pharmaceutical Ingredient (API) site in Chunan passes FDA US Audit
2016.10.24
/
Savior Lifetec Corporation's Injection Plant (IP) in Tainan, Taiwan Passes US FDA Audit
2016.09.29
/
Savior Lifetec Co., Ltd. --Active Pharmaceutical Ingredient (API) site in Nanke passes FDA US Audit
2016.04.28
/
Savior Lifetec Co. Receives US ANDA Approval for Meropenem
2015.09.08
/
Savior is officially listed on TWSE
2015.06.26
/
Savior Lifetec Corporation's Application to be listed was approved by the TPEx (Gretai Securities Market) Board of Directors
<
1
/
2
/
3
>